Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 1/2016

01.01.2016 | Original Paper

Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS

verfasst von: Linda M. Collins, Kari C. Kugler, Marya Viorst Gwadz

Erschienen in: AIDS and Behavior | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

To move society toward an AIDS-free generation, behavioral interventions for prevention and treatment of HIV/AIDS must be not only effective, but also cost-effective, efficient, and readily scalable. The purpose of this article is to introduce to the HIV/AIDS research community the multiphase optimization strategy (MOST), a new methodological framework inspired by engineering principles and designed to develop behavioral interventions that have these important characteristics. Many behavioral interventions comprise multiple components. In MOST, randomized experimentation is conducted to assess the individual performance of each intervention component, and whether its presence/absence/setting has an impact on the performance of other components. This information is used to engineer an intervention that meets a specific optimization criterion, defined a priori in terms of effectiveness, cost, cost-effectiveness, and/or scalability. MOST will enable intervention science to develop a coherent knowledge base about what works and does not work. Ultimately this will improve behavioral interventions systematically and incrementally.
Fußnoten
1
To save space, we will use the word “effectiveness” to refer to either efficacy or effectiveness where it is not necessary to distinguish between the two.
 
2
We subscribe to the definition of the role of pilot testing in intervention science that has been outlined by Leon et al. [68]: “The fundamental purpose of conducting a pilot study is to examine the feasibility of an approach that is intended to ultimately be used in a larger scale study… A pilot study… is not used for hypothesis testing” (p. 626).
 
3
Everything said about factorial experiments in this article assumes that the data from the experiment are to be analyzed in a standard factorial analysis of variance (ANOVA) using effect coding rather than dummy coding. We strongly recommend the use of effect coding, which, unlike dummy coding, produces estimates of main effects and interactions that are always consistent with the classic definitions found in most statistics textbooks; see Collins et al. [3].
 
Literatur
1.
Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30(1):65–73.PubMedCrossRef
2.
Collins LM, Murphy SA, Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent e-health interventions. Am J Prev Med. 2007;32:S112–8.PubMedPubMedCentralCrossRef
3.
Collins LM, Baker TB, Mermelstein RJ, Piper ME, Jorenby DE, Smith SS, et al. The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med. 2011;41(2):208–26.PubMedPubMedCentralCrossRef
4.
Collins LM, Nahum-Shani I, Almirall D. Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART). Clin Trials. 2014;11:426–34.PubMedPubMedCentralCrossRef
5.
Seeley J, Watts CH, Kippax S, Russell S, Heise L, Whiteside A. Addressing the structural drivers of HIV: a luxury or necessity for programmes? J Int AIDS Soc. 2012;15(Suppl 1):17397.PubMedCentral
6.
Latkin C, Kuramoto S, Davey-Rothwell M, Tobin K. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behav. 2010;14(5):1159–68.PubMedPubMedCentralCrossRef
7.
Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16((3Suppl 2)):18734.PubMedPubMedCentral
8.
Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–77.PubMedPubMedCentralCrossRef
9.
Hagan H, Jenness S, Wendel T, Murrill C, Neaigus A, Gelpi-Acosta C. Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas. Int J STD AIDS. 2010;21(8):580–3.PubMedCrossRef
10.
Oster AM, Sternberg M, Nebenzahl S, Broz D, Xu F, Hariri S, et al. Prevalence of HIV, sexually transmitted infections, and viral hepatitis by urbanicity, among men who have sex with men, injection drug users, and heterosexuals in the United States. Sex Transm Dis. 2014;41(4):272–9.PubMedCrossRef
11.
12.
Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRef
13.
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2011;8(1):62–72.PubMedPubMedCentralCrossRef
14.
15.
Dosekun O, Fox J. An overview of the relative risks of different sexual behaviours on HIV transmission. Curr Opin HIV AIDS. 2010;5(4):291–7.PubMedCrossRef
16.
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281–90.PubMedPubMedCentralCrossRef
17.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedPubMedCentralCrossRef
18.
Gwads MV, BCAP Collaborative Research Team. STTR with heterosexuals at high risk for HIV: Preliminary findings. In: Annual Meetings of the Society for Prevention Research; San Francisco, CA2013.
19.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.PubMedCrossRef
20.
Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107(1):51–9.PubMedCrossRef
21.
Kahler CW, Wray TB, Pantalone DW, Kruis RD, Mastroleo NR, Monti PM, et al. Daily associations between alcohol use and unprotected anal sex among heavy drinking HIV-positive men who have sex with men. AIDS Behav. 2014;19:422–30.CrossRef
22.
Kelly JA, DiFranceisco WJ, Lawrence JSS, Amirkhanian YA, Anderson-Lamb M. Situational, partner, and contextual factors associated with level of risk at most recent intercourse among Black men who have sex with men. AIDS Behav. 2014;18(1):26–35.PubMedCrossRef
23.
Woolf SE, Maisto SA. Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav. 2009;13(4):757–82.PubMedCrossRef
24.
Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.PubMedPubMedCentralCrossRef
25.
Braithwaite RS, Bryant KJ. Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health. 2010;33(3):280.PubMedPubMedCentral
26.
Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180.PubMedPubMedCentralCrossRef
27.
Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54(2):197–203.PubMed
28.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedPubMedCentralCrossRef
29.
Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. Aids. 2009;23(11):1397–404.PubMedCrossRef
30.
Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J. Causal considerations on alcohol and HIV/AIDS—a systematic review. Alcohol Alcohol. 2010;45(2):159.PubMedCrossRef
31.
32.
Lewis MA, Patrick ME, Litt DM, Atkins DC, Kim T, Blayney JA, et al. Randomized controlled trial of a web-delivered personalized normative feedback intervention to reduce alcohol-related risky sexual behavior among college students. J Consult Clin Psychol. 2014;82(3):429.PubMedPubMedCentralCrossRef
33.
Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443.PubMedPubMedCentralCrossRef
34.
Office of National AIDS Policy. National HIV/AIDS strategy: Update of the 2014 federal actions to achieve national goals and improve outcomes along the HIV care continuum. Washington, DC: 2014.
35.
Miller WR, Rollnick S. Motivational interviewing: helping people change. New York: Guilford Press; 2012.
36.
Ajzen I. From intentions to actions: a theory of planned behavior. New York: Springer; 1985.
37.
Vansteenkiste M, Sheldon KM. There’s nothing more practical than a good theory: integrating motivational interviewing and self-determination theory. Br J Clin Psychol. 2006;45(1):63–82.PubMedCrossRef
38.
Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977.
39.
Bandura A. Social foundations of thought and action. Englewood Cliffs: Prentice Hall; 1986.
40.
41.
Kalichman SC, Grebler T, Amaral CM, McNerey M, White D, Kalichman MO, et al. Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. J Gen Intern Med. 2013;28(3):399–405.PubMedPubMedCentralCrossRef
42.
Nyamathi A, Flaskerud JH, Leake B, Dixon EL, Lu A. Evaluating the impact of peer, nurse case-managed, and standard HIV risk-reduction programs on psychosocial and health-promoting behavioral outcomes among homeless women. Res Nurs Health. 2001;24(5):410–22.PubMedCrossRef
43.
Purcell DW, Latka MH, Metsch LR, Latkin CA, Gómez CA, Mizuno Y, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46:S35–47.PubMedCrossRef
44.
Brown JL, Littlewood RA, Vanable PA. Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city. AIDS Care. 2013;25(9):1149–58.PubMedPubMedCentralCrossRef
45.
Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Thóra B, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (cART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12(1):142.PubMedPubMedCentralCrossRef
46.
Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend. 2011;117(2):158–63.PubMedPubMedCentralCrossRef
47.
Cruess DG, Kalichman SC, Amaral C, Swetzes C, Cherry C, Kalichman MO. Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS. Ann Behav Med. 2012;43(2):189–97.PubMedPubMedCentralCrossRef
48.
Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMed
49.
Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.PubMedPubMedCentralCrossRef
50.
Norton WE, Amico KR, Fisher WA, Shuper PA, Ferrer RA, Cornman DH, et al. Information–motivation–behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV + patients in clinical care. AIDS care. 2010;22(8):979–87.PubMedPubMedCentralCrossRef
51.
Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45(10):1377–85.PubMedCrossRef
52.
Oh DL, Sarafian F, Silvestre A, Brown T, Jacobson L, Badri S, et al. Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr. 2009;52(2):290.PubMedPubMedCentralCrossRef
53.
Harris GE, Larsen D. HIV peer counseling and the development of hope: perspectives from peer counselors and peer counseling recipients. AIDS Patient Care STDs. 2007;21(11):843–60.PubMedCrossRef
54.
Guillory J, Chang P, Henderson CR Jr, Shengelia R, Lama S, Warmington M, et al. Piloting a text message-based social support intervention for patients with chronic pain: establishing feasibility and preliminary efficacy. Clin J Pain. 2015;31(6):548–56.PubMedCrossRef
55.
Mo PK, Coulson NS. Exploring the communication of social support within virtual communities: a content analysis of messages posted to an online HIV/AIDS support group. Cyberpsychol Behav. 2008;11(3):371–4.PubMedCrossRef
56.
Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg RD, Coomes CM, et al. Addressing HIV knowledge, risk reduction, social support, and patient involvement using SMS: results of a proof-of-concept study. J Health Commun. 2012;17(sup1):128–45.PubMedCrossRef
57.
Safren SA, Reisner SL, Herrick A, Mimiaga MJ, Stall R. Mental health and HIV risk in men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S74.PubMedPubMedCentralCrossRef
58.
McIntosh RC, Rosselli M. Stress and coping in women living with HIV: a meta-analytic review. AIDS Behav. 2012;16(8):2144–59.PubMedCrossRef
59.
Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012;43(2):161–71.PubMedPubMedCentralCrossRef
60.
Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol Rev. 2014:1–20.
61.
62.
Kalichman SC, Cherry C, Kalichman MO, Amaral CM, White D, Pope H, et al. Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. Am J Public Health. 2011;101(3):531–8.PubMedPubMedCentralCrossRef
63.
Kaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr. 2014;66:S250–8.PubMedPubMedCentralCrossRef
64.
Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep. 2012;9(4):287–312.PubMedCrossRef
65.
Charania MR, Marshall KJ, Lyles CM, Crepaz N, Kay LS, Koenig LJ, et al. Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of US-based studies, 1996–2011. AIDS Behav. 2014;18(4):646–60.PubMedPubMedCentralCrossRef
66.
Simoni JM, Nelson KM, Franks JC, Yard SS, Lehavot K. Are peer interventions for HIV efficacious? A systematic review. AIDS Behav. 2011;15(8):1589–95.PubMedPubMedCentralCrossRef
67.
Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202–24.PubMedPubMedCentralCrossRef
68.
69.
Dziak JJ, Collins LM, Wagner AT. FactorialPowerPlan SAS macro suite users’ guide. 1st ed. University Park: The Methodology Center, Penn State; 2013.
70.
Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial Experiments: efficient Tools for Evaluation of Intervention Components. Am J Prev Med. 2014;47(4):498–504.PubMedPubMedCentralCrossRef
71.
Kuehl RO, Kuehl R. Design of experiments: statistical principles of research design and analysis. Pacific Grove, CA: Duxbury Press; 2000.
72.
Pellegrini CA, Hoffman SA, Collins LM, Spring B. Optimization of remotely delivered intensive lifestyle treatment for obesity using the multiphase optimization strategy: Opt-IN study protocol. Contemp Clin Trials. 2014;38:251–9.PubMedPubMedCentralCrossRef
73.
Strecher VJ, McClure JB, Alexander GL, Chakraborty B, Nair VN, Konkel JM, et al. Web-based smoking-cessation programs: results of a randomized trial. Am J Prev Med. 2008;34(5):373–81.PubMedPubMedCentralCrossRef
74.
Sas S. Guide SUs. Cary: SAS Institute Inc; 1990. p. 355.
75.
Kugler K, Trail J, Dziak J, Collins L. Effect coding versus dummy coding in analysis of data from factorial experiments. Technical Report, 2012.
76.
Collins LM, Trail JB, Kugler KC, Baker TB, Piper ME, Mermelstein RJ. Evaluating individual intervention components: making decisions based on the results of a factorial screening experiment. Transl Behav Med. 2014;4:238–51.PubMedPubMedCentralCrossRef
77.
Caldwell LL, Smith EA, Collins LM, Graham JW, Lai M, Wegner L, et al. Translational research in South Africa: evaluating implementation quality using a factorial design. Child & youth care forum (2012). Springer, New York
78.
Caldwell LL, Patrick ME, Smith EA, Palen L, Wegner L. Influencing adolescent leisure motivation: intervention effects of HealthWise South Africa. J Leis Res. 2010;42(2):203–20.PubMedPubMedCentral
79.
80.
McKay JR. Is there a case for extended interventions for alcohol and drug use disorders? Addiction. 2005;100(11):1594–610.PubMedCrossRef
81.
Rivera DE, Pew MD, Collins LM. Using engineering control principles to inform the design of adaptive interventions: a conceptual introduction. Drug Alcohol Depend. 2007;88:S31–40.PubMedPubMedCentralCrossRef
82.
Lagoa CM, Bekiroglu K, Lanza ST, Murphy SA. Designing adaptive intensive interventions using methods from engineering. J Consult Clin Psychol. 2014;82(5):868.PubMedPubMedCentralCrossRef
83.
Navarro-Barrientos J-E, Rivera DE, Collins LM. A dynamical model for describing behavioural interventions for weight loss and body composition change. Math Comput Model Dyn Syst. 2011;17(2):183–203.PubMedPubMedCentralCrossRef
84.
Savage JS, Downs DS, Dong Y, Rivera DE. Control systems engineering for optimizing a prenatal weight gain intervention to regulate infant birth weight. Am J Public Health. 2014;104:e1–8.CrossRef
85.
Johnson BT, Michie S, Snyder LB. Effects of behavioral intervention content on HIV prevention outcomes: a meta-review of meta-analyses. J Acquir Immune Defic Syndr. 2014;66:S259–70.PubMedCrossRef
86.
Pals SL, Murray DM, Alfano CM, Shadish WR, Hannan PJ, Baker WL. Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches. Am J Public Health. 2008;98(8):1418.PubMedPubMedCentralCrossRef
Metadaten
Titel
Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS
verfasst von
Linda M. Collins
Kari C. Kugler
Marya Viorst Gwadz
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe Sonderheft 1/2016
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1145-4

Weitere Artikel der Sonderheft 1/2016

AIDS and Behavior 1/2016 Zur Ausgabe

Original Paper

Developmental Cognitive Neuroscience of Adolescent Sexual Risk and Alcohol Use

Original Paper

Reducing Risky Sex Among College Students: Prospects for Context-Specific Interventions

Original Paper

Does Drinking Improve the Quality of Sexual Experience?: Sex-Specific Alcohol Expectancies and Subjective Experience on Drinking Versus Sober Sexual Occasions

Original Paper

Protocol for a Controlled Experiment to Identify the Causal Role of Acute Alcohol Consumption in Condomless Sex among HIV-Positive MSM: Study Procedures, Ethical Considerations, and Implications for HIV Prevention

Original Paper

The Person and the Partner: Individual Differences Moderate the Relationship Between Partner Feedback and Condom Use

Original Paper

Toward Development of Enhanced Preventive Interventions for HIV Sexual Risk among Alcohol-Using Populations: Confronting the ‘Mere Pause from Thinking’

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise